Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic ma…
Biotechnology
US, Tarrytown [HQ]
Lobbying Analysis
Lobbying · US Senate · InfluenceHistory
Download| FY | Quarter | Expense For Lobby Disclosure | LDA Reference |
|---|---|---|---|
| 2024 | 2 | $6,000,000 | LD-2 : 07/22/24 |
| 2024 | 1 | $6,000,000 | LD-2 : 04/22/24 |
| 2024 | 1 | $5,000,000 | LD-2 : 04/04/24 |
| 2023 | 4 | $5,000,000 | LD-2 : 02/05/24 |
| 2023 | 4 | $6,000,000 | LD-2 : 01/22/24 |
Get PRO Today
With PRO you will unlock 3 more lobbying disclosures for Regeneron Pharmaceuticals, Inc.